Hydrophobic Membrane Adsorbers for Large-Scale Downstream Processing - This alternative to column chromatography is suitable for flow-through as well as bind-and-elute purification operations. - BioPh

ADVERTISEMENT

Hydrophobic Membrane Adsorbers for Large-Scale Downstream Processing
This alternative to column chromatography is suitable for flow-through as well as bind-and-elute purification operations.


BioPharm International Supplements


A Phenyl Membrane Adsorber for Large-Scale Purification


Table 1. Dynamic binding capacities (DBC) at 10% breakthrough for Sartobind phenyl membrane adsorber (3 mL membrane volume) challenged with three different model proteins. All proteins were prepared as 1 g/L solutions in 50 mM phosphate buffer at pH 7.0 with varying amounts of ammonium sulfate, and loading was done at 10 mL/min (18 s residence time).
The Sartobind phenyl hydrophobic membrane adsorber was recently introduced to the market.18,19 It is assembled into 30-layer radial flow process capsules with an 8-mm bed height. The HIC membrane adsorber resulted from the combination of a newly designed macroporous membrane structure and covalently attached hydrophobic phenyl ligand. This membrane structure was designed for high flow rates and binding capacities. Furthermore, the hydrophilic stabilized regenerated cellulose membrane support possesses excellent mechanical and chemical robustness and demonstrates minimal unspecific interaction with proteins, even at high concentrations of a lyotropic salt.19 The functionalized membrane exhibits increasing binding capacity in increasing ammonium sulfate concentrations, as expected in HIC. Table 1 describes the binding capacity at 10% breakthrough for Sartobind phenyl challenged with three different model proteins.


Figure 1. Flow-through mode operation with Sartobind phenyl membrane adsorber to remove high molecular weight (HMW) aggregates for the purification of an E. coli expressed protein. The figure shows the percentage of aggregates bound onto the membrane at increasing salt conditions.
In a recent paper, the separation properties of the HIC membrane were evaluated and compared to those of a traditional HIC resin, phenyl Sepharose FF (low sub) from GE Healthcare (Chalfont St. Giles, UK).19 Using a protein mixture of cytochrome C, trypsinogen, and a polyclonal IgG, Sartobind phenyl demonstrated better resolution than the HIC resin under the experimental conditions used for the evaluation. In addition to the bind-and-elute operation, the authors demonstrated the application of Sartobind phenyl in flow-through mode for aggregate removal in a purification process for a recombinant protein. The protein was loaded with varying amounts of ammonium sulfate such that the aggregates bound while the monomer did not. After loading, the membrane was washed with deionized water to elute the bound aggregates. The aggregate removal increased with increased ammonium sulfate concentration, as shown in Figure 1. Protein yield was >95%, regardless of the salt conditions used in the loading buffer.


blog comments powered by Disqus

ADVERTISEMENT

Lonza Introduces Risk Assessment Platform for Biopharmaceuticals
June 19, 2013
GSK Receives Offer for its Thrombosis Brands and Related Manufacturing Site
June 19, 2013
Elan Proceeds with Formal Sale Process of Company; Royalty Pharma Drops Bid
June 19, 2013
RAME-HART Technology Helps Boost Vaccine Production in Emerging Markets
June 19, 2013
Pfizer Wins Multibillion-Dollar Settlement from Teva and Sun for Infringement of Protonix Patent
June 19, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International Supplements,
Click here